Okay, let's tackle this question about the plasma half-life of carbimazole. First, I need to recall what carbimazole is used for. It's an antithyroid medication, right? Used in hyperthyroidism, like in Graves' disease. Now, the question is about its plasma half-life. I remember that carbimazole is a prodrug. Wait, what's the half-life of methimazole, which is the active form? Because carbimazole is metabolized to methimazole in the body. So maybe the half-life is related to methimazole's half-life?

Let me think. The half-life of methimazole is around 6-10 hours. But wait, carbimazole itself might have a different half-life. I think the plasma half-life of carbimazole is shorter than methimazole because it's converted into the active form. So maybe the half-life is around 1-2 hours? But I'm not sure. Alternatively, maybe the question is tricking me because the half-life of the active metabolite is longer, but the parent drug's half-life is shorter.

Wait, I should check standard pharmacology references. From what I remember, carbimazole is rapidly absorbed and metabolized to methimazole. The plasma half-life of carbimazole is about 1-2 hours, while methimazole has a longer half-life of 4-6 hours. So the correct answer would be in the range of 1-2 hours. But the options here aren't provided, so I need to structure the explanation based on that knowledge.

Now, the core concept here is the pharmacokinetics of carbimazole, specifically its plasma half-life and its prodrug nature. The correct answer is based on the metabolic conversion to methimazole. The incorrect options would be other half-lives that don't align with this. For example, if an option says 24 hours, that's too long. If it's 30 minutes, that's too short. The other options might be related to other antithyroid drugs like propylthiouracil, which has a different half-life.

The clinical pearl here is to remember that carbimazole's half-life is shorter than its active metabolite, methimazole. This is important for dosing intervals and understanding its effect in the body. So the key take away is that carbimazole is a prodrug with a shorter half-life, and the active form has a longer half-life, which affects treatment duration and frequency.

**Core Concept**
The plasma half-life of **carbimazole**, a prodrug of methimazole, is a key pharmacokinetic parameter. Carbimazole is rapidly metabolized to **methimazole**, its active form, which inhibits thyroid hormone synthesis. Understanding its half-life is critical for dosing intervals and therapeutic efficacy in hyperthyroidism management.

**Why the Correct Answer is Right**
Carbimazole has a **plasma half-life of ~1-2 hours** due to rapid hepatic conversion to methimazole. While methimazole itself has a longer half-life (4-6 hours), the parent drug’s short half-life necessitates multiple daily doses. This distinction is vital for clinicians to optimize treatment and minimize side effects.

**Why Each Wrong Option is Incorrect**
**Option A:** Likely

✓ Correct Answer: B. 8 hours